Ray Co., Ltd. announced that it has received KRW 25 billion in funding from KB Securities Co., Ltd., L&C Bio Co., Ltd, Samsung Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Hanwha Investment & Securities Co., Ltd.
March 26, 2024
Share
On March 27, 2024, Ray Co., Ltd. closed the transaction.
Ray Co.,Ltd is a Korea-based company mainly engaged in the development, production and distribution of dental imaging medical devices. Along with its subsidiaries, the Company manufactures and sells digital diagnostic systems and digital therapy solution products. Digital diagnostic systems include dental radiography equipments such as x-ray systems and cone beam computed tomography (CBCT) systems. Digital therapy solutions include three dimensional (3D) scanning, dental computer aided design (CAD), and 3D printers used in prosthodontics, orthodontics, and implant surgery. The Company distributes its products within domestic market and to overseas markets.
Ray Co., Ltd. announced that it has received KRW 25 billion in funding from KB Securities Co., Ltd., L&C Bio Co., Ltd, Samsung Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Hanwha Investment & Securities Co., Ltd.
RAY CO., LTD. 
